19Indexed trials
mesh condition
Down Syndrome
Intelligence
Down Syndrome intelligence: 19 indexed trials, 6 recruiting studies, 19 sponsors across 6 countries.
6Recruiting
19Sponsors
6Countries
Leading sponsors
AC Immune SA11 recruiting
Academy Het Dorp10 recruiting
Alnylam Pharmaceuticals11 recruiting
Eisai Inc.10 recruiting
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)10 recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau11 recruiting
Hoffmann-La Roche10 recruiting
Institut Jerome Lejeune10 recruiting
LuMind IDSC Foundation10 recruiting
Michael Rafii, MD, PhD11 recruiting
Riphah International University11 recruiting
University Hospital, Grenoble11 recruiting
Geographic activity
United States11trials
Spain3trials
France2trials
Pakistan2trials
Netherlands1trials
United Kingdom1trials
Leading interventions
ACI-24.060 at Dose A in Study Part 21trials
ACI-24.060 at Dose B in Study Part 1a1trials
ACI-24.060 at Dose B in Study Part 21trials
ACI-24.060 at Dose C in Study Part 1a1trials
ACI-24.060 at Dose C in Study Part 21trials
ACI-24.060 with an additional adjuvant at Dose D in Study Part 1b1trials
ACI-24.060 with an additional adjuvant at Dose E in Study Part 1b1trials
Aricept (donepezil hydrochloride)1trials
Bicycle Training Intervention1trials
Coping With and Caring for Infants With Special Needs1trials
Donanemab1trials
ACI-24.060 at Dose A in Study Part 1a1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.